Today, I link to The New England Journal of Medicine’s CME course, Management and Treatment of Obesity in Primary Care.
All that follows is from the above resource which I will be reviewing.
An Evolving Landscape
This free CME program from NEJM Group explores the latest evidence on lifestyle, pharmacological, and surgical interventions, as well as recent progress in understanding the causes of obesity. Consisting of four distinct learning opportunities, each activity aims to equip primary care clinicians to navigate the complex, evolving landscape of obesity management.
CME/CE Program Components
Mechanisms, Pathophysiology, and Management of Obesity
(Recommended Starting Point)
On Demand Course
CME Credit: 1 AMA PRA Category 1 Credit™This seminal NEJM Review Article has been annotated by authors Steven B. Heymsfield, M.D. and Thomas A. Wadden, Ph.D. to include recent advances in the treatment and practice of obesity medicine.
Lifestyle Interventions in the Management of Obesity
CME Credit: 1.5 AMA PRA Category 1 Credits™
Through this enduring material, you will gain a comprehensive understanding of how to talk with patients about their weight, how to assess obesity in your patients, and how to incorporate healthy lifestyle changes. Join national obesity experts for a case-based discussion on the latest evidence regarding factors that contribute to weight gain, as well as the data behind dietary interventions. Come away better prepared to speak knowledgeably with your patients, answer their questions, and provide more effective obesity management.
Moderator: Adam H. Gilden, M.D., M.S.C.E.
Speakers: Meghan L. Butryn, Ph.D., and Beverly Tchang, M.D., D.A.B.O.M.
Recent Advancements in the Management of Obesity with a Focus on Pharmacotherapies
CME Credit: 1.5 AMA PRA Category 1 Credits™
Through this enduring material, you will gain a comprehensive understanding of recent advancements in the management of obesity with a focus on pharmacotherapies. Join national obesity experts for a case-based discussion on medications that are approved for chronic weight management. You will understand the mechanism of the new medications that act on gut hormone receptors such as the GLP-1 and GIP receptors, with practical tips on using these in clinical practice. You can also expect a preview of new agents in the pipeline.
Moderator: Adam H. Gilden, M.D., M.S.C.E., D.A.B.O.M.
Speakers: Rebecca M. Andrick, D.O., F.O.M.A., D.A.B.O.M., and Jaime Almandoz, M.D., M.B.A., F.T.O.S., D.A.B.O.M.
Management of Complications of Obesity
CME Credit: 1.5 AMA PRA Category 1 Credits™
Through this enduring material, you will gain a comprehensive understanding of how to assess and manage the complications of obesity. Join national obesity experts for a case-based discussion that includes an overview of old and new approaches to fatty liver disease and tips on optimizing cardiorenal disease in the presence of obesity.
Moderator: Adam H. Gilden, M.D., M.S.C.E.
Speakers: Heather Laskey, M.D., and Chiadi Ericson Ndumele, M.D., Ph.D., M.H.S.TAKE THIS COURSE AND EARN CME Accreditation & Disclosure Information
